FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

J Mardiak

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Geographic Areas

Slovakia

Co-author Network

Publications

TOP 3
Eduard Vrdoljak; tudor ciuleanu; Galina Kharkevich; J Mardiak; Michal Mego; Peeter Padrik; Luboš Petruželka; Gunta Purkalne; Yaroslav Shparyk; Breda Skrbinc; Cezary Szczylik; Laszlo Torday
Optimizing treatment for patients with metastatic renal cell carcinoma in the Central and Eastern European region.
Michal Mego; Jana Obertova; Patrik Palacka; Stefan Porsok; Jan Rajec; Zuzana Sycova-Mila; Stefania Liskova; J Mardiak
Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis.
Michal Mego; M Reckova; J Obertova; Z Sycova-Mila; K Brozmanova; J Mardiak
Increased cardiotoxicity of sorafenib in sunitinib-pretreated patients with metastatic renal cell carcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of J Mardiak (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Eduard Vrdoljak; tudor ciuleanu; Galina Kharkevich; J Mardiak; Michal Mego; Peeter Padrik; Luboš Petruželka; Gunta Purkalne; Yaroslav Shparyk; Breda Skrbinc; Cezary Szczylik; Laszlo Torday
Optimizing treatment for patients with metastatic renal cell carcinoma in the Central and Eastern European region.
Expert opinion on pharmacotherapy 2012;13(2):159-74.
2011: Michal Mego; Jana Obertova; Patrik Palacka; Stefan Porsok; Jan Rajec; Zuzana Sycova-Mila; Stefania Liskova; J Mardiak
Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis.
Breast (Edinburgh, Scotland) 2011;20(5):478-80.
2007: Michal Mego; M Reckova; J Obertova; Z Sycova-Mila; K Brozmanova; J Mardiak
Increased cardiotoxicity of sorafenib in sunitinib-pretreated patients with metastatic renal cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(11):1906-7.
2007: Michal Mego; M Recková; Z Sycova-Mila; J Obertova; K Brozmanova; T Salek; J Mardiak
Bevacizumab in a growing teratoma syndrome. Case report.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(5):962-3.
2007: D Svetlovska; J Mardiak; V Kristova
Trastuzumab in the adjuvant treatment of breast cancer.
Bratislavské lekárske listy 2007;108(2):100-3.
2007: J Mardiak; T Sálek; Z Sycová-Milá; J Obertová; M Recková; Michal Mego; Z Hlavatá; K Brozmanová; Z Risnyovzská; D Svetlovská; I Koza
Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study.
Neoplasma 2007;54(3):240-5.
2006: Michal Mego; R Koncekova; E Mikuskova; L Drgona; L Ebringer; L Demitrovicova; I Nemova; Jan Trupl; J Mardiak; I Koza; Vladimír Zajac
Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Phase II study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2006;14(3):285-90.
2005: D Svetlovska; J Mardiak
Treatment strategy of early-stage breast cancer.
Bratislavské lekárske listy 2005;106(11):362-5.
2005: J Mardiak; T Sálek; Z Sycová-Milá; J Obertová; Z Hlavatá; Michal Mego; M Recková; I Koza
Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study.
Neoplasma 2005;52(6):497-501.
2005: J Mardiak; T Sálek; Z Sycová-Milá; J Obertová; Z Hlavatá; Michal Mego; M Recková; I Koza
Gemcitabine plus cisplatine and paclitaxel (GCP) in second-line treatment of germ cell tumors (GCT): a phase II study.
Neoplasma 2005;52(3):243-7.
2005: Michal Mego; L Ebringer; L Drgona; J Mardiak; Jan Trupl; R Greksak; I Nemova; E Oravcova; Vladimír Zajac; I Koza
Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Pilot study phase I.
Neoplasma 2005;52(2):159-64.
2000: J Mardiak; L Bohunický; J Chovanec; T Sálek; I Koza
Adjuvant clodronate therapy in patients with locally advanced breast cancer--long term results of a double blind randomized trial. Slovak Clodronate Collaborative Group.
Neoplasma 2000;47(3):177-80.
2000: J Mardiak; T Sálek; Z Sycova-Milá; J Sufliarsky; M Baláz; I Koza
Carboplatin and cyclophosphamide in the treatment of metastatic seminoma.
Neoplasma 2000;47(4):244-7.
2000: J Mardiak; P Fuchsberger; J Lakota; T Sálek; Z Sycová-Milá; M Drahokoupilová; M Baláz; I Koza
Sequential intermediate high-dose therapy with etoposide, ifosfamide and cisplatin for patients with germ cell tumors.
Neoplasma 2000;47(4):239-43.
1999: Vladimir Krcméry; Marianna Mrazova; A Kunova; Eva Grey; J Mardiak; L Jurga; A Sabo; J Sufliarsky; L Sevcikova; D Sorkovska; D West; Jan Trupl; J Novotny; F Mateicka
Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1999;7(6):428-31.
1998: Stanislav Spanik; J Sufliarsky; J Mardiak; D Sorkovska; Jan Trupl; A Kunova; Eva Kukuckova; Viera Rusnakova; Andrea Demitrovicova; P Pichna; Iveta Krupova; K Kralovicova; F Mateićka; D West; Vladimir Krcméry
Predictors of mortality in bacteremic cancer patients: retrospective analysis of 64 deaths occurring among 262 bacteremic episodes.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1998;6(3):291-4.
1998: Z Horváthová; S Spánik; J Sufliarsky; J Mardiak; P Pichna; E Pichnova; S Krajcík; M Mráz; B Chmelík; J Dacok; J Beresova; I Krúpová; A Hrachová; Jan Trupl; A Kunová; Vladimir Krcméry
Bacteremia due to methicillin-resistant staphylococci occurs more frequently in neutropenic patients who received antimicrobial prophylaxis and is associated with higher mortality in comparison to methicillin-sensitive bacteriemia.
International journal of antimicrobial agents 1998;10(1):55-8.
1998: Vladimir Krcméry; S Spánik; S Grausová; Jan Trupl; I Krupová; A Roidová; T Sálek; J Sufliarsky; J Mardiak
Candida parapsilosis fungemia in cancer patients--incidence, risk factors and outcome.
Neoplasma 1998;45(5):336-42.
1997: Vladimir Krcméry; Z Jesenska; Stanislav Spanik; J Gyarfas; J Nogova; R Botek; J Mardiak; J Sufliarsky; J Sisolakova; M Vanickova; A Kunova; M Studena; Jan Trupl
Fungaemia due to Fusarium spp. in cancer patients.
The Journal of hospital infection 1997;36(3):223-8.
1997: Stanislav Spanik; Jan Trupl; A Kunova; L Drgona; T Salek; J Mardiak; Eva Kukuckova; M Studena; P Pichna; E Oravcova; Eva Grey; Pavol Koren; J Svec; J Lacka; J Sufliarsky; Vladimir Krcméry
Risk factors, aetiology, therapy and outcome in 123 episodes of breakthrough bacteraemia and fungaemia during antimicrobial prophylaxis and therapy in cancer patients.
Journal of medical microbiology 1997;46(6):517-23.
1997: Vladimir Krcméry; Stanislav Spanik; K Stopkova; Silvia Grausova; J Mardiak; Pavol Koren; J Sepesi; J Pechan; A Demitrovicová; K Kralovicová; J Novotny
Bacteremia in cancer patients with solid tumors undergoing chemotherapy versus surgery: risk factors, etiology and outcome in 276 patients.
Journal of chemotherapy (Florence, Italy) 1997;9(3):232-7.
1997: Vladimir Krcméry; A Kunova; J Mardiak
Nosocomial Cryptococcus laurentii fungemia in a bone marrow transplant patient after prophylaxis with ketoconazole successfully treated with oral fluconazole.
Infection 1997;25(2):130.
1997: M Mrázová-Studená; L Drgona; S Spánik; I Krúpová; M Baláz; P Pichna; Pavol Koren; J Sufliarsky; J Mardiak; A Kunová; Jan Trupl; Vladimir Krcméry
Bacteremia in neutropenic versus nonneutropenic cancer patients: etiology and outcome in 401 episodes.
Neoplasma 1997;44(5):314-8.
1996: S Spánik; Vladimir Krcméry; Jan Trupl; I Ilavská; L Hel'pianska; L Drgona; T Salek; J Mardiak; E Kukucková; M Studená; P Pichna; E Oravcová; Eva Grey; Pavol Koren; T Minárik; J Lacka; J Sufliarsky
Breakthrough bacteraemic and fungaemic episodes during antimicrobial prophylaxis and therapy in cancer patients: analysis of risk factors, etiology, therapy and outcome in 123 episodes.
Bratislavské lekárske listy 1996;97(11):652-9.
1996: Vladimir Krcméry; E Kunova; Z Jesenska; Jan Trupl; Stanislav Spanik; J Mardiak; M Studena; Eva Kukuckova
Invasive mold infections in cancer patients: 5 years' experience with Aspergillus, Mucor, Fusarium and Acremonium infections.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1996;4(1):39-45.
1993: Jan Trupl; M Májek; J Mardiak; Z Jesenská; Vladimir Krcméry
Acremonium infection in two compromized patients.
The Journal of hospital infection 1993;25(4):299-301.
1993: J Mardiak; A Danisovicová; Jan Trupl; J Sloboda; Z Jesenská; Vladimir Krcméry
Three cases of fatal infection due to Fusarium solani in patients with cancer.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;17(5):930-2.
1993: P Sajben; T Minárik; E Tomásik; J Mardiak; A Danisovicovà; T Trupl; Vladimir Krcméry
Fluconazol plus ofloxacin in prophylaxis of infections in patients with acute leukemia: a comparative study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1993;1(4):214-6.
1992: Vladimir Krcméry; I Koza; P Fuchsberger; S Spánik; Jan Trupl; J Gyarfás; J Sufliarsky; F Agh; A Horváth; J Mardiak
Candidosis, aspergillosis and zygomycosis in an oncology department.
Mycoses 1992;35(7-8):189-91.
1992: Vladimir Krcméry; I Koza; J Mardiak; P Fuchsberger; S Spánik; Jan Trupl; M Horníková; Z Kusenda; J Sufliarsky; J Svec
Netilmicin plus ceftriaxone versus amikacin plus ceftriaxone in the treatment of infections in granulocytopenic patients.
Chemotherapy 1992;38(1):74-6.
1992: I Koza; J Mardiak; L Bohunický; L Svancárová; P Fuchsberger; J Gyárfás; I Horák; S Spánik; J Sufliarsky; Z Thalmeinerová
Intensive combination chemotherapy (TTL-I protocol) of large cell and immunoblastic lymphomas--long-term observation.
Neoplasma 1992;39(1):43-7.
1991: Vladimir Krcméry; I Koza; P Fuchsberger; J Mardiak; S Spánik; J Sufliarsky; J Gyarfás; Z Kusenda; M Horníková; Z Thalmeinerová
[Various antibiotics in the monotherapy and combined therapy of infections in cancer patients. Retrospective study of 290 patients].
Casopís lékar̆ů c̆eských 1991;130(6):177-85.
1991: Eva Brandsteterová; V Chovancová; I Koza; J Mardiak; J Hal'ko
Determination of suramin in clinical samples using HPLC.
Neoplasma 1991;38(4):425-32.
1991: Vladimir Krcméry; I Koza; M Hornikova; P Fuchsberger; Stanislav Spanik; J Mardiak; J Sufliarsky; M Blahova; V Savko; C Migom
Fluconazole in the treatment of mycotic oropharyngeal stomatitis and esophagitis in neutropenic cancer patients.
Chemotherapy 1991;37(5):343-5.
1991: I Koza; L Bohunický; K Mociková; J Gyárfás; L Svancárová; J Mardiak; S Spánik; P Fuchsberger; Z Thalmeinerová; J Sufliarsky
Comparison of two non-cross-resistant combinations (ABVP/LOPP) with COPP plus bleomycin in the treatment of advanced Hodgkin's disease.
Neoplasma 1991;38(6):583-93.
1990: Vladimir Krcméry; M Horníková; I Koza; P Fuchsberger; S Spánik; J Sufliarsky; J Mardiak; L Sitáni; P Milosovic
[Peroral ciprofloxacin in the therapy of infections in oncology patients].
Casopís lékar̆ů c̆eských 1990;129(42):1337-8.
1989: I Koza; L Bohunický; L Svancárová; J Mardiak; J Gyárfás; V Cerný
Treatment of advanced Hodgkin's disease with modified MOPP regimens. A long-term observation.
Neoplasma 1989;36(6):709-18.
1981: I Koza; V Cerný; I Horák; L Bohunický; J Gyarfás; L Svancárová; J Hal'ko; J Mardiak; T Zonnenschein; Z Thalmeinerová
Treatment of adult acute lymphoblastic leukemia: results of two trials.
Neoplasma 1981;28(4):473-84.